A 43-year-old man with chronic active hepatitis C was treated with int
erferon-beta (IFN-beta) at a dosage of 6x10(6) IU/day for a planned 6-
week period. Ocular hyperemia, ophthalmalgia, and increased intraocula
r pressure in the right eye developed 20 days after the start of treat
ment. Intraocular pressure remained high, even after discontinuation o
f IFN therapy, laser therapy, and iridectomy. Two days later, the righ
t eye was removed because perforation had occurred. The ocular symptom
s that developed in this case were thought to have been caused and exa
cerbated by IFN administration.